Current status of low molecular weight heparins in clinical practice

J Assoc Physicians India. 2000 Feb;48(2):216-20.
No abstract available

MeSH terms

  • Coronary Disease / drug therapy
  • Fibrinolytic Agents / adverse effects
  • Fibrinolytic Agents / pharmacology*
  • Fibrinolytic Agents / therapeutic use
  • Heparin, Low-Molecular-Weight / adverse effects
  • Heparin, Low-Molecular-Weight / pharmacology*
  • Heparin, Low-Molecular-Weight / therapeutic use
  • Humans

Substances

  • Fibrinolytic Agents
  • Heparin, Low-Molecular-Weight